What Does Vertex Pharmaceuticals Do?

Total employees5400
HeadquartersBoston
Founded1989

Vertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule, cell, and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, and alpha-1 antitrypsin deficiency.

Where Is Vertex Pharmaceuticals's Headquarters?

Vertex Pharmaceuticals officeVertex Pharmaceuticals officeVertex Pharmaceuticals officeVertex Pharmaceuticals office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the central hub for Vertex's global operations, including research and development, corporate strategy, and administrative functions.

Notable Features:

The headquarters comprises two interconnected, LEED Gold certified, state-of-the-art buildings at Fan Pier, featuring advanced research laboratories, collaborative workspaces, and views of Boston Harbor.

Work Culture:

Emphasizes innovation, collaboration, and a patient-centric mission. The space is designed to foster interaction, scientific discovery, and employee well-being.

HQ Significance:

Represents Vertex's commitment to scientific excellence and its growth as a leading biotech firm. Its location in Boston's innovation hub facilitates collaboration with academic and medical institutions.

Values Reflected in HQ: Innovation, cutting-edge science, sustainability, patient focus, and collaboration are reflected in the HQ's design, functionality, and amenities.

Location:

Vertex Pharmaceuticals operates globally with a network of offices and research sites across North America, Europe, Australia, and Latin America. Key functions supported globally include research and development, manufacturing and supply chain management, commercial operations, medical affairs, regulatory affairs, and essential corporate functions. This widespread presence is dedicated to discovering, developing, and delivering transformative medicines to patients with serious diseases worldwide.

Street Address:

50 Northern Avenue

City:

Boston

State/Province:

MA

Country:

USA

Where Else Does Vertex Pharmaceuticals Operate Around the World?

Paddington, London, United Kingdom

Address: Level 9, The Point, 37 North Wharf Road, Paddington, London W2 1AF, UK

Supports the delivery of Vertex's transformative medicines to patients internationally and engages with regional healthcare systems, regulatory bodies, and stakeholders.

San Diego, California, USA

Address: 3215 Merryfield Row, San Diego, CA 92121, USA

Leverages the rich biotech ecosystem in San Diego to advance scientific research and development for new treatments for serious diseases.

Milton Park, Abingdon, Oxfordshire, United Kingdom

Address: 88 Jubilee Avenue, Milton Park, Abingdon, OX14 4RW, UK

Contributes to Vertex's global R&D efforts by tapping into the UK's strong life sciences talent pool and world-class research infrastructure in the Oxford biotech cluster.

Buying Intent Signals for Vertex Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Vertex Pharmaceuticals? Meet the Executive Team

As of April 2025, Vertex Pharmaceuticals' leadership includes:

Reshma Kewalramani, M.D., FASN - Chief Executive Officer and President
Stuart A. Arbuckle - Executive Vice President and Chief Operating Officer
Charles F. Wagner - Executive Vice President and Chief Financial Officer
David Altshuler, M.D., Ph.D. - Executive Vice President, Global Research and Chief Scientific Officer
Carmen Bozic, M.D. - Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer
Paul M. Silva - Executive Vice President and Chief Commercial Officer
Nia Tatsis, Ph.D. - Executive Vice President and Chief Regulatory and Quality Officer
Michael J. LaCascia - Executive Vice President and Chief Human Resources Officer

Who's Investing in Vertex Pharmaceuticals?

Vertex Pharmaceuticals has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock, Inc.
State Street Corporation
FMR LLC (Fidelity Management & Research)
Capital Research Global Investors
Wellington Management Company LLP

What Leadership Changes Has Vertex Pharmaceuticals Seen Recently?

Hire1
Exits0

In the past 12 months, Vertex Pharmaceuticals notably strengthened its commercial leadership with the appointment of Paul M. Silva as Executive Vice President and Chief Commercial Officer. No other major C-suite executive departures or hires were prominently announced during this period based on available public information.

New Appointments:

Paul M. Silva, Paul M. Silva appointed as Executive Vice President and Chief Commercial Officer, bringing extensive experience to lead Vertex's global commercial strategy and execution.

What Technology (Tech Stack) Is Used byVertex Pharmaceuticals?

Discover the tools Vertex Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Vertex Pharmaceuticals Email Formats and Examples

Vertex Pharmaceuticals commonly utilizes the email format combining the first initial directly followed by the last name, for its corporate communications (e.g., jdoe@vrtx.com). This format is prevalent across the organization.

first_initialLast@vrtx.com

Format

rKewalramani@vrtx.com

Example

90%

Success rate

What's the Latest News About Vertex Pharmaceuticals?

Vertex Pharmaceuticals Press Release • May 29, 2024

Vertex Pharmaceuticals and CRISPR Therapeutics Present New Data for CASGEVY® (exagamglogene autotemcel) at EHA 2024

Vertex and CRISPR Therapeutics announced they will present new data on CASGEVY, their gene-editing therapy, demonstrating consistent and sustained clinical benefits for patients with sickle cell disease and transfusion-dependent beta thalassemia, including improvements in quality of life....more

Vertex Pharmaceuticals Press Release • May 7, 2024

Vertex Pharmaceuticals Reports Strong First-Quarter 2024 Financial Results

Vertex announced robust financial performance for Q1 2024, highlighted by a 13% increase in product revenue to $2.69 billion, driven by strong sales of its cystic fibrosis treatments, and reaffirmed its full-year 2024 financial guidance. The company also emphasized continued investment in its diverse R&D pipeline....more

Vertex Pharmaceuticals Press Release • April 2, 2024

Vertex Pharmaceuticals Announces Positive Phase 3 Results for Vanzacaftor Triple Combination in CF

Vertex reported successful results from two pivotal Phase 3 trials (SKYLINE 102 and SKYLINE 103) of its next-generation vanzacaftor/tezacaftor/deutivacaftor triple combination therapy for cystic fibrosis in patients 12 years and older. The therapy showed statistically significant improvements in lung function and other key measures, with plans for global regulatory submissions by mid-2024....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Vertex Pharmaceuticals, are just a search away.